TIM-3在宫颈癌外周血T细胞中的表达及相关性研究
方晓丹, 李娟, 戴姝艳中国医科大学附属盛京医院妇产科, 沈阳 110004
收稿日期:
2019-10-31出版日期:
2020-11-30发布日期:
2020-10-31通讯作者:
戴姝艳E-mail:daishy2014@163.com作者简介:
方晓丹(1991-),女,硕士研究生.基金资助:
沈阳市科学技术计划(F14-158-9-41,20-205-4-028)关键词: T细胞免疫球蛋白黏连蛋白-3, CD8+T细胞, CD4+T细胞, 宫颈癌
Abstract: Objective In this study,we aimed to investigate the expression of T cell immunoglobulin and mucin domain-containing protein 3(TIM-3)in T cells from the peripheral blood of cervical cancer patients,and to explore the relationship between TIM-3 and the development of cervical cancer. Methods CD4+T cells and CD8+T cells in the peripheral blood of patients with cervical cancer and CIN were significantly reduced compared with those from patients without cervical lesions,and the expression levels of TIM-3 on the surface of CD4+T and CD8+T cells were significantly increased,in a statistically significant fashion;on the other hand,no statistically significant differences were observed in samples from CIN versus cervical cancer patients. Compared with stage Ⅰ to Ⅱ,TIM-3 expression in the levels of peripheral blood of CD4+T and CD8+T cells were significantly increased in stage Ⅲ to Ⅳ cervical cancer patients(P<0.05). Analysis of different clinical factors showed that the expression of TIM-3 in peripheral blood T cells was not correlated with age,lymph node positivity,tumor size,or squamous cell carcinoma antigen level(P>0.05). Conclusion TIM-3 may affect the development and progression of cervical cancer;our data may support the use of TIM-3 for the development of novel immunotherapeutic approaches effective against cervical cancer.
Key words: T cell immunoglobulin and mucin domains-containing protein 3, CD4+T cells, CD8+T cells, cervical cancer
PDF全文下载地址:
https://journal.cmu.edu.cn/CN/article/downloadArticleFile.do?attachType=PDF&id=2635